Tag: CELZ

Starting 2022 Off the Right Way

Ringing in the New Year with Options Updates

We’ve been tracking several longer-term options plays in recent sessions, and today for the first report of the new calendar year, we’ve got some updates on the moves we’ve observed.

Starting off with BBIO, we were on top of that one from Tuesday of last week, watching as it gradually pressed to new highs each day. The stock itself has run from 12.06-17.34 during that span (+44%). We were targeting the BBIO 02/18 $12.50-15 Calls and thus far here are the total increases we’ve observed in those plays:

BBIO 02/18 $12.50-15 Calls 
$12.50: 1.85-5.11 (+176%)
$15: 1.50-3.60 (+140%)

On the same day last Tuesday, we signaled interest in some MRNA targets as well, highlighting the MRNA 01/21 $250-260 Calls and they too produced some nice increases on the week when all was said and done.

MRNA 01/21 $250-260 Calls
$250: 11.45-22.04 (+92%)
$252.50: 11.17-20.00 (+79%)
$255: 10.21-19.04 (+86%)
$257.50: 10.55-17.90 (+70%)
$260: 9.10-17.00 (+87%)

Fresh Options Ideas: 
SPY 01/03 $476-478 Calls*
FB Weekly $337.50-340 Calls 

*Please don’t attempt to trade options on the day of their expiration unless you are an experienced trader with access to disposable funds!

Extended Watchlist:
IMMX, CELZ, BLCT, AFI, PTE, HMBL, IQST, PRMK, RGBP, BLFE, NSAV, AMLH

Fresh Options Ideas, CURR Investor Webcast Info

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we were just pointing out in yesterday morning’s premarket report, CURE was slated to present at LD Micro Main Event Conference yesterday afternoon, and that event went off without a hitch. You can view the company’s full 20-minute presentation by registering at the LD Micro website HERE, navigating to Tuesday’s tab, and looking in the 2PM slot for CURE Pharmaceuticals.

It’s also important to note that CURE will be hosting a Zoom webcast tomorrow at 4PM EST, regarding, among other things, the company’s current strategic positioning.  

You can register to participate in the conference, and/or listen to an archived copy at a later time, at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Fresh Options Ideas 
BOIL Weekly $23-25 Calls
TTC Weekly $90-95 Calls
FDX Weekly $285-290 Calls

Extended Watchlist:
BITW, BLDV, TMXN, DIGAF, MMEDF, CELZ

GRST, CELZ Recaps & More

OTC Recaps 

As we’ve mentioned several times over the last month, we have been supplementing quite a bit of OTC-traded stocks in addition to our routine options watchlists. Here are a couple of movers that we’ve been tracking. 

Ethema Health Corp. GRST – We initially alerted on GRST on the morning of June 5th, at which time the stock was trading in the super-subpenny basement at ,0002 a share. Yesterday, the stock attained an impressive new high at .0027. That’s a monster gain of 1250% in a period of just eight trading days, and it adds yet another thousand-percenter to our 2020 track record, which contains several at this point.
_____

Creative Medical Technology Holdings, Inc. CELZ – We put CELZ on our extended watchlist in yesterday’s premarket report, and the stock produced a fairly nice intraday gain on the session.

From a low of .0044, the stock saw a high of .0073, which works out to a 66% rip. If it manages to crack recent resistance at .0075, there;s not a whole lot stopping CELZ from making a run into penny-plus territory.

Fresh Options Ideas:

GRPN Weekly $28-29 Calls & 07/02 $30-31 Calls
SIEB 07/17 $5 Calls
ATAX 07/17 $5 Calls

Special Note: H&R Block stands to see increased business flow over the next month with the tax deadline having been pushed back due to the coronavirus. We’re going to signal the HRB 07/17 $19-20 Calls for a possible swing trade.

Extended Watchlist:
UONEK, CLWD, ATDS, VSMR, AMNP